Literature DB >> 6051574

The synthesis of taurocholic and glycocholic acids by preparations of human liver. I. Distribution of activity between subcellular fractions.

T Scherstén.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6051574

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  7 in total

Review 1.  Hepatic lipid secretion and cholelithiasis.

Authors:  R D Soloway; J L Thistle; L J Schoenfield
Journal:  Am J Dig Dis       Date:  1971-05

2.  A radiochemical assay for glycine N-acyltransferase activity. Some properties of the enzyme in rat and rabbit.

Authors:  M O James; J R Bend
Journal:  Biochem J       Date:  1978-05-15       Impact factor: 3.857

3.  Kinetic studies on the enzymes conjugating bile acids with taurine and glycine in bovine liver.

Authors:  D A Vessey; M H Crissey; D Zakim
Journal:  Biochem J       Date:  1977-04-01       Impact factor: 3.857

4.  The metabolism of 3alpha, 7alpha, 12alpha-trihydorxy-5beta-cholestan-26-oic acid in two siblings with cholestasis due to intrahepatic bile duct anomalies. An apparent inborn error of cholic acid synthesis.

Authors:  R F Hanson; J N Isenberg; G C Williams; D Hachey; P Szczepanik; P D Klein; H L Sharp
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

Review 5.  Biosynthesis of bile acids in mammalian liver.

Authors:  S Kevresan; K Kuhajda; J Kandrac; J P Fawcett; M Mikov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jul-Sep       Impact factor: 2.441

6.  Identification of bile acid-CoA: amino acid N-acyltransferase in rat kidney.

Authors:  J B Kwakye; M R Johnson; S Barnes; W E Grizzle; R B Diasio
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

7.  Biliary lipid composition in heterozygous familial hypercholesterolemia and influence of treatment with probucol.

Authors:  N Tanno; S Oikawa; M Koizumi; H Kotake; H Hirakawa; Y Kanazawa; T Toyota
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.